US 8501184
High affinity human antibodies to PCSK9
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 8501184 (High affinity human antibodies to PCSK9) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/08, A61P